Haemonetics Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Haemonetics Corp.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
/ 
Frequently asked questions
To buy Haemonetics Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Haemonetics Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Haemonetics Corp. is HAE:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Haemonetics Corp. has its primary listing on New York Stock Exchange. You can trade Haemonetics Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Haemonetics Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Haemonetics Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Haemonetics Corp..